SNCA and Parkinson disease: Reduced PLC activity and PI(4,5)P2 metabolism in PD cortex, perhaps following the accumulation of α-synuclein which appears to inhibit PLC enzymes. Increased PI(4,5)P2 in PD patient substantia nigra.